- Home
- ACIU vs RICK Comparison
ACIU vs RICK Comparison
Compare ACIU & RICK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACIU | RICK |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 229.7M | 196.2M |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | ACIU | RICK |
|---|---|---|
| Price | $2.12 | $27.53 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.58 | N/A |
| AVG Volume (30 Days) | ★ 195.8K | 32.5K |
| Earning Date | 11-04-2026 | 08-06-2026 |
| Dividend Yield | N/A | ★ 1.18% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.16 |
| Revenue | N/A | ★ $144,896,000.00 |
| Revenue This Year | $422.39 | $16.98 |
| Revenue Next Year | $377.85 | N/A |
| P/E Ratio | ★ N/A | $168.25 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.02 | $20.76 |
| 52 Week High | $3.90 | $32.00 |
Technical Indicators
Market Signals| Indicator | ACIU | RICK |
|---|---|---|
| Relative Strength Index (RSI) | 41.11 | 47.02 |
| Support Level | $2.09 | $25.21 |
| Resistance Level | $2.57 | $29.32 |
| Average True Range (ATR) | 0.19 | 0.92 |
| MACD | -0.00 | -0.14 |
| Stochastic Oscillator | 18.69 | 19.51 |
Price Performance
Historical ComparisonAbout ACIU AC Immune SA
AC Immune SA is a clinical stage biopharmaceutical company advancing a portfolio of programs strategically focused on pioneering Precision Medicine for neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The company has one segment. The company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About RICK RCI Hospitality Holdings Inc.
RCI Hospitality Holdings Inc through its subsidiaries, owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, and room rentals.